Research ArticleClinical Investigations
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Katsutoshi Furukawa, Aiko Ishiki, Naoki Tomita, Tetsuro Tago, Kotaro Hiraoka, Shoichi Watanuki, Miho Shidahara, Masayasu Miyake, Yoichi Ishikawa, Rin Matsuda, Akie Inami, Takeo Yoshikawa, Yoshihito Funaki, Ren Iwata, Manabu Tashiro, Kazuhiko Yanai, Hiroyuki Arai and Yukitsuka Kudo
Journal of Nuclear Medicine February 2016, 57 (2) 208-214; DOI: https://doi.org/10.2967/jnumed.115.164848
Ryuichi Harada
1Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
Nobuyuki Okamura
1Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
2Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Shozo Furumoto
4Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Katsutoshi Furukawa
5Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; and
Aiko Ishiki
5Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; and
Naoki Tomita
5Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; and
Tetsuro Tago
4Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Kotaro Hiraoka
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Shoichi Watanuki
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Miho Shidahara
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
6Division of Medical Physics, Tohoku University School of Medicine, Sendai, Japan
Masayasu Miyake
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Yoichi Ishikawa
4Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Rin Matsuda
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Akie Inami
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Takeo Yoshikawa
2Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
Yoshihito Funaki
4Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Ren Iwata
4Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Manabu Tashiro
3Division of Cyclotron Nuclear Medicine, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan
Kazuhiko Yanai
2Department of Pharmacology, Tohoku University School of Medicine, Sendai, Japan
Hiroyuki Arai
5Department of Geriatrics and Gerontology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; and
Yukitsuka Kudo
1Division of Neuro-imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan
4Division of Radiopharmaceutical Chemistry, Cyclotron and Radioisotope Center, Tohoku University, Sendai, Japan

Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 2
February 1, 2016
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Katsutoshi Furukawa, Aiko Ishiki, Naoki Tomita, Tetsuro Tago, Kotaro Hiraoka, Shoichi Watanuki, Miho Shidahara, Masayasu Miyake, Yoichi Ishikawa, Rin Matsuda, Akie Inami, Takeo Yoshikawa, Yoshihito Funaki, Ren Iwata, Manabu Tashiro, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo
Journal of Nuclear Medicine Feb 2016, 57 (2) 208-214; DOI: 10.2967/jnumed.115.164848
18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease
Ryuichi Harada, Nobuyuki Okamura, Shozo Furumoto, Katsutoshi Furukawa, Aiko Ishiki, Naoki Tomita, Tetsuro Tago, Kotaro Hiraoka, Shoichi Watanuki, Miho Shidahara, Masayasu Miyake, Yoichi Ishikawa, Rin Matsuda, Akie Inami, Takeo Yoshikawa, Yoshihito Funaki, Ren Iwata, Manabu Tashiro, Kazuhiko Yanai, Hiroyuki Arai, Yukitsuka Kudo
Journal of Nuclear Medicine Feb 2016, 57 (2) 208-214; DOI: 10.2967/jnumed.115.164848
Jump to section
Related Articles
Cited By...
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- Preclinical Characterization of the Tau PET Tracer [18F]SNFT-1: Comparison of Tau PET Tracers
- First-in-Humans Evaluation of 18F-SMBT-1, a Novel 18F-Labeled Monoamine Oxidase-B PET Tracer for Imaging Reactive Astrogliosis
- 18F-SMBT-1: A Selective and Reversible PET Tracer for Monoamine Oxidase-B Imaging
- High-contrast in-vivo imaging of tau pathologies in Alzheimers and non-Alzheimers disease tauopathies
- Biomarkers for the diagnosis of Alzheimers disease, dementia Lewy body, frontotemporal dementia and vascular dementia
- Comparative In Vitro and In Vivo Quantifications of Pathologic Tau Deposits and Their Association with Neurodegeneration in Tauopathy Mouse Models
- Correlations of 18F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease
- 18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome
- Biodistribution and Radiation Dosimetry for the Tau Tracer 18F-THK-5351 in Healthy Human Subjects
- Kinetic Modeling of the Tau PET Tracer 18F-AV-1451 in Human Healthy Volunteers and Alzheimer Disease Subjects
- In Vivo Comparison of Tau Radioligands 18F-THK-5351 and 18F-THK-5317
- Modeling Strategies for Quantification of In Vivo 18F-AV-1451 Binding in Patients with Tau Pathology
- Pharmacokinetic Evaluation of the Tau PET Radiotracer 18F-T807 (18F-AV-1451) in Human Subjects
- Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging
- In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET
- Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
- Hybrid PET/MR Imaging in Neurology: Present Applications and Prospects for the Future